- Home
- EARN vs AMRN Comparison
EARN vs AMRN Comparison
Compare EARN & AMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EARN
- AMRN
- Stock Information
- Founded
- EARN 2012
- AMRN 1989
- Country
- EARN United States
- AMRN Ireland
- Employees
- EARN N/A
- AMRN N/A
- Industry
- EARN Real Estate Investment Trusts
- AMRN Biotechnology: Pharmaceutical Preparations
- Sector
- EARN Real Estate
- AMRN Health Care
- Exchange
- EARN Nasdaq
- AMRN Nasdaq
- Market Cap
- EARN 213.3M
- AMRN 216.0M
- IPO Year
- EARN 2013
- AMRN 1993
- Fundamental
- Price
- EARN $5.88
- AMRN $15.80
- Analyst Decision
- EARN Buy
- AMRN Strong Sell
- Analyst Count
- EARN 2
- AMRN 1
- Target Price
- EARN $6.00
- AMRN $12.00
- AVG Volume (30 Days)
- EARN 232.7K
- AMRN 172.9K
- Earning Date
- EARN 08-11-2025
- AMRN 07-30-2025
- Dividend Yield
- EARN 16.37%
- AMRN N/A
- EPS Growth
- EARN N/A
- AMRN N/A
- EPS
- EARN N/A
- AMRN N/A
- Revenue
- EARN $35,893,000.00
- AMRN $214,112,000.00
- Revenue This Year
- EARN $3.72
- AMRN N/A
- Revenue Next Year
- EARN $18.60
- AMRN N/A
- P/E Ratio
- EARN N/A
- AMRN N/A
- Revenue Growth
- EARN 43.30
- AMRN N/A
- 52 Week Low
- EARN $4.33
- AMRN $7.08
- 52 Week High
- EARN $7.20
- AMRN $17.49
- Technical
- Relative Strength Index (RSI)
- EARN 65.08
- AMRN 60.01
- Support Level
- EARN $5.71
- AMRN $16.12
- Resistance Level
- EARN $5.79
- AMRN $17.49
- Average True Range (ATR)
- EARN 0.06
- AMRN 0.78
- MACD
- EARN 0.01
- AMRN -0.13
- Stochastic Oscillator
- EARN 90.74
- AMRN 34.42
About EARN Ellington Residential Mortgage REIT of Beneficial Interest
Ellington Credit Co is focused on corporate collateralized loan obligations (CLOs). It focuses on acquiring, investing in, and managing secondary CLO mezzanine debt and equity tranches. The company relies on risk management, including disciplined liquidity management and selective use of credit hedges, to preserve book value during times of stress. It also leverages Ellington's proprietary technology, analytics, and risk management systems to enhance underwriting and investment selection and to guide ongoing portfolio monitoring and surveillance.
About AMRN Amarin Corporation plc
Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.